This national registry study compared crosslinked (XLPE) versus conventional (non-XLPE) all-polyethylene glenoid components in stemmed anatomic total shoulder arthroplasty done for osteoarthritis. It asked whether the wear-related revision benefit of XLPE seen in hip and knee arthroplasty carries over to the shoulder. It also tested whether that benefit varies by humeral head size and by specific prosthesis combination.
When you have a choice of bearing surface for a stemmed anatomic total shoulder, pick crosslinked polyethylene, especially for humeral heads 44 mm and larger.
The mechanism is the same story you already know from hip and knee: conventional polyethylene sheds more wear particles, which drive osteolysis and aseptic glenoid loosening. Loosening was the cause that most cleanly separated the two groups and explains the revision gap.
Watch the timing. The curves are identical early and only diverge after about 1.5 years, so short-term follow-up will miss this effect. That is a common trap in reading arthroplasty survivorship data.
Read this as Level III registry evidence, not a randomized trial. The benefit was not seen in every implant or in small heads, and unmeasured confounders like glenoid version and surgeon technique still matter. The practical rule holds: use XLPE when available, and expect the biggest payoff in larger heads.
This national registry study compared crosslinked (XLPE) versus conventional (non-XLPE) all-polyethylene glenoid components in stemmed anatomic total shoulder arthroplasty done for osteoarthritis. It asked whether the wear-related revision benefit of XLPE seen in hip and knee arthroplasty carries over to the shoulder. It also tested whether that benefit varies by humeral head size and by specific prosthesis combination.
When you have a choice of bearing surface for a stemmed anatomic total shoulder, pick crosslinked polyethylene, especially for humeral heads 44 mm and larger.
The mechanism is the same story you already know from hip and knee: conventional polyethylene sheds more wear particles, which drive osteolysis and aseptic glenoid loosening. Loosening was the cause that most cleanly separated the two groups and explains the revision gap.
Watch the timing. The curves are identical early and only diverge after about 1.5 years, so short-term follow-up will miss this effect. That is a common trap in reading arthroplasty survivorship data.
Read this as Level III registry evidence, not a randomized trial. The benefit was not seen in every implant or in small heads, and unmeasured confounders like glenoid version and surgeon technique still matter. The practical rule holds: use XLPE when available, and expect the biggest payoff in larger heads.